Interní Med. 2013; 15(3-4): 105-109
Non-Hodgkin´s lymphomas (NHL) are malignant diseases with rising incidence. On the other hand, most of them belong among the
best treatable cancers. Diagnostics and staging have currently improved especially due to immunohistochemistry, molecular biology
studies and positron emission tomography, however, for timely diagnosis, high index of suspicion and correctly performed sample
collection is essential. In most non-Hodgkin´s lymphomas, immunochemotherapy plays crucial role and has improved prognosis in
almost all types of B-lymphomas. Most of T-cell lymphomas have still dismal prognosis, however, these diseases are rather rare in
Czech population.
Published: March 20, 2013 Show citation